NCT04514744

Brief Summary

Skeletal muscle plays several different roles in the promotion and maintenance of health and well-being. The loss of muscle mass that occurs with aging, chronic muscle wasting diseases, and physical inactivity puts people at an increased risk of frailty and becoming insulin resistant, and therefore imposes a significant burden on health care spending. Resistance exercise participation has proven particularly effective for increasing muscle mass and strength. This effectiveness can be used by health care practitioners in a rehabilitation setting to promote the recovery of individuals who have undergone involuntary periods of muscular unloading (i.e. limb immobilization caused by a sports injury or reconstructive surgery). However, there is large variability in the amount of muscle mass and strength that people gain following participation in resistance exercise. Some individuals fail to increase the size of their muscle (low responders) whereas others show vary large increases in muscle size (high responders) in response to the same resistance training program. People also show differences in the amount of muscle tissue they lose when they have a limb immobilized. To circumvent variability across individuals, the investigators utilized a within-person paired Hypertrophy and Atrophy ('HYPAT') strategy that reduced response heterogeneity by \~40% (Available at: https://ssrn.com/abstract=3445673). Specifically, one leg performed resistance training for 10 weeks to induce hypertrophy, whereas the other leg underwent single-leg immobilization for 2 weeks to induce atrophy. The primary goal of the study will be to gain insight into the molecular responses to an acute period of single-leg immobilization and resistance exercise (8 days). The investigators will use an integrated systems biology approach to monitor the individual rates of over one hundred different muscle proteins.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 17, 2020

Completed
1.4 years until next milestone

Study Start

First participant enrolled

December 30, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

October 2, 2024

Status Verified

October 1, 2024

Enrollment Period

8 months

First QC Date

June 29, 2020

Last Update Submit

October 1, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Dynamic Proteomics

    The investigators will use deuterated water and skeletal muscle biopsies, paired with sensitive Gas Chromatography-Mass Spectrometry techniques to calculate the individual synthesis rate of over one hundred different skeletal muscle proteins.

    Baseline, Day 5, Day 9 and Day 14 (Post)

  • Change in Integrated Rates of Muscle Protein Synthesis

    The investigators will use deuterated water and skeletal muscle biopsies to calculate the cumulative synthesis of skeletal muscle proteins.

    Baseline, Day 5, Day 9 and Day 14 (Post)

Secondary Outcomes (3)

  • Change in Lean Mass Using Dual X-Ray Absorptiometry

    Baseline, Day 5 and Day 14 (Post)

  • Change in Muscle Strength using an Isokinetic Dynamometer

    Baseline, Day 5 and Day 14 (Post)

  • Change in Muscle Cross-Sectional Area using Ultrasonography

    Baseline, Day 5 and Day 14 (Post)

Study Arms (2)

Unilateral Immobilization

EXPERIMENTAL

One leg will undergo 14 days of single-leg immobilization, by means of a removable knee brace.

Procedure: Knee bracing

Unilateral Resistance Exercise

EXPERIMENTAL

One leg will undergo 4 sessions of unilateral resistance exercise, over the course of 8 days. Specifically, participants will be asked to perform leg press and leg extension.

Other: Unilateral Resistance Exercise Training

Interventions

Knee bracingPROCEDURE

Participants will have one leg immobilized, by means of a removable Don Joy Knee Brace. Participants will be expected to keep the knee brace on for 14 days, completely prevent weight bearing on the immobilized leg, and use crutches.

Unilateral Immobilization

Participants will perform resistance training on 4 occasions throughout an 8 day time period.

Unilateral Resistance Exercise

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy males, between the ages of 18 and 30 y
  • Body Mass Index between 18.5 and 30.0 kg/m2
  • Able and willing to provide informed consent

You may not qualify if:

  • A history of neuromuscular disorders or muscle/bone wasting diseases.
  • Any acute or chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, insulin-dependent or insulin-independent diabetes, or the presence of any other metabolic disease - all of which will be determined via a medical history screening questionnaire.
  • The use of any medications known to affect protein metabolism (glucocorticoids, non-steroidal anti-inflammatory medication, or prescription strength acne medication, etc.).
  • A (family) history of thrombosis.
  • The use of anticoagulant medications.
  • Consumption of tobacco-containing products.
  • Excessive alcohol consumption (\>21 units/wk).
  • History of bleeding diathesis, platelet or coagulation disorders, or anti-platelet/anticoagulation therapy.
  • Exercise participation \>2 days/wk (structured resistance and/or aerobic-type exercise)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exercise Metabolism Research Laboratory, McMaster Univeristy

Hamilton, Ontario, L8S 4K1, Canada

Location

MeSH Terms

Conditions

Motor ActivityMuscular Disorders, AtrophicHypertrophy

Condition Hierarchy (Ancestors)

BehaviorMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: In a randomized fashion, one participant will have one leg assigned to unilateral immobilization, and the other leg will undergo unilateral resistance exercise training, for 8 days.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 29, 2020

First Posted

August 17, 2020

Study Start

December 30, 2021

Primary Completion

September 1, 2022

Study Completion

July 1, 2025

Last Updated

October 2, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

All participants will be assigned a unique subject ID, and therefore, other researchers involved with analyses will not have access to identifying participant information.

Locations